MetaCap

Aurora Cannabis (ACB) vs Regencell Bioscience (RGC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aurora Cannabis (ACB) has outperformed Regencell Bioscience (RGC) over the past year, losing 1.2% versus a loss of 66.5%. Over five years, RGC leads with a +508.8% price change compared with -93.9% for ACB. Regencell Bioscience is the larger company by market cap ($2.07 billion vs $273.5 million), about 7.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACB-1.19%RGC-66.51%
+343%+129%-86%
Nov 21, 20251 yearNov 20, 2026
ACB-94.09%RGC+483.15%
+6607%+3096%-415%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACB versus RGC key metrics
MetricACBRGC
Share price$4.16$4.18
Market cap$273.50M$2.07B
1-day change-2.35%-4.13%
YTD return-1.42%-80.10%
1-year return-1.19%-66.51%
5-year return-93.87%+508.80%
EPS (TTM)$-0.19$-0.02
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)—$-11.70M
52-week high$6.36$69.00
52-week low$2.56$4.12
Distance from 52-week high-34.59%-93.94%
Analyst consensusunderperform—
Average volume1.31M234.51K
Shares outstanding65.74M495.88M
Employees1,02810
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Regencell Bioscience is about 7.6 times larger than Aurora Cannabis by market value ($2.07B vs $273.50M).
  • ACB has outperformed RGC by 65.3 percentage points over the past year.

About Aurora Cannabis

ACB stock →

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.

Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees

About Regencell Bioscience

RGC stock →

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.

Health Care · Medicinal Chemicals and Botanical Products · 10 employees

ACB vs RGC FAQ

Which is bigger, Aurora Cannabis or Regencell Bioscience?

Regencell Bioscience (RGC) is larger, with a market capitalization of $2.07B compared with $273.50M for Aurora Cannabis (ACB).

Which stock has performed better over the past year, ACB or RGC?

ACB returned -1.19% over the past 12 months, compared with -66.51% for RGC (price return, excluding dividends). Past performance does not predict future results.

Are Aurora Cannabis and Regencell Bioscience in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons